PROSPECTUS SUPPLEMENT (To Prospectus dated May 20, 2022)Sales Agreement • May 6th, 2022 • New York
We previously entered into a sales agreement, or the sales agreement, with Leerink Partners LLC, or Leerink Partners, relating to the sale of shares of our common stock, par value $0.0001 per share. In accordance with the terms of the sales agreement, under this prospectus supplement and the accompanying prospectus, we may offer and sell shares of our common stock having an aggregate offering price of up to $25,000,000 from time to time through Leerink Partners, acting as our sales agent. We previously filed a sales agreement prospectus with the Securities and Exchange Commission on May 10, 2022, or the prior prospectus, relating to the offering and sale pursuant to the sales agreement of shares of our common stock having an aggregate offering price of up to $50.0 million through Leerink Partners, acting as our sales agent. As of the date of this prospectus supplement, we have issued and sold shares of common stock for aggregate gross sale proceeds of approximately $50.0 million pursua